Home › Free Stock Grades › ALKS
Alkermes plc (ALKS) Stock Grade
ALKS · Healthcare
B+
Market Cap
$6.7B
P/E Ratio
19.1
Revenue Growth (YoY)
-5.3%
Net Margin
16.4%
Return on Equity
13.3%
Dividend Yield
None
About Alkermes plc's fundamentals
Alkermes is a specialty pharmaceutical company with a market capitalization of $6.7 billion, currently trading at a P/E ratio of 19.1. The company is experiencing revenue headwinds, with year-over-year revenue declining 5.3%, though it maintains a solid net margin of 16.4%, indicating profitable operations despite the sales contraction. Return on equity stands at 13.3%, suggesting moderate efficiency in generating returns from shareholder capital. The company does not currently pay a dividend.